The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | Common | G01767105 | 42,432,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | Common | 03753U106 | 491,699,991 | 12,222,222 | SH | SOLE | 12,222,222 | 0 | 0 | |||
| ARGENX SE | Sponsored ADR | 04016X101 | 730,250,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| ARROWHEAD PHARMACEUTICALS INC | Common | 04280A100 | 670,889,937 | 10,699,999 | SH | SOLE | 10,699,999 | 0 | 0 | |||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 1,157,945,625 | 5,062,500 | SH | SOLE | 5,062,500 | 0 | 0 | |||
| AVALO THERAPEUTICS | Common | 05338F306 | 21,051,300 | 1,410,000 | SH | SOLE | 1,410,000 | 0 | 0 | |||
| CELCUITY INC | Common | 15102K100 | 3,050,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
| CELCUITY INC | Common | 15102K100 | 385,222,500 | 3,375,000 | SH | SOLE | 3,375,000 | 0 | 0 | |||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 454,017,673 | 11,430,455 | SH | SOLE | 11,430,455 | 0 | 0 | |||
| CYTOKINETICS INC | Common | 23282W605 | 219,699,978 | 3,333,333 | SH | SOLE | 3,333,333 | 0 | 0 | |||
| DAMORA THERAPEUTICS INC | Common | 36322Q206 | 97,979,700 | 3,783,000 | SH | SOLE | 3,783,000 | 0 | 0 | |||
| DEFINIUM THERAPEUTICS INC | Common | 24477V105 | 94,500,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | |||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 25,308,000 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | |||
| KRYSTAL BIOTECH INC | Common | 501147102 | 746,257,548 | 2,888,888 | SH | SOLE | 2,888,888 | 0 | 0 | |||
| KYMERA THERAPEUTICS INC | Common | 501575104 | 622,571,678 | 7,474,747 | SH | SOLE | 7,474,747 | 0 | 0 | |||
| LEXEO THERAPEUTICS INC | Common | 52886X107 | 10,762,500 | 1,875,000 | SH | SOLE | 1,875,000 | 0 | 0 | |||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 951,763,208 | 1,818,181 | SH | SOLE | 1,818,181 | 0 | 0 | |||
| MANNKIND CORP | Common | 56400P706 | 5,390,000 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | Common | 67576A100 | 104,308,050 | 12,315,000 | SH | SOLE | 12,315,000 | 0 | 0 | |||
| REVOLUTION MEDICINES INC | Common | 76155X100 | 227,997,179 | 2,344,444 | SH | SOLE | 2,344,444 | 0 | 0 | |||
| SEPTERNA INC | Common | 81734D104 | 32,140,125 | 1,337,500 | SH | SOLE | 1,337,500 | 0 | 0 | |||
| SOLENO THERAPEUTICS INC | Common | 834203309 | 77,004,000 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 315,977,751 | 6,555,555 | SH | SOLE | 6,555,555 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | Common | 877619106 | 96,999,000 | 21,700,000 | SH | SOLE | 21,700,000 | 0 | 0 | |||
| TERNS PHARMACEUTICALS INC | Common | 880881107 | 300,240,400 | 5,695,000 | SH | SOLE | 5,695,000 | 0 | 0 | |||
| UNIQURE NV | Common | N90064101 | 97,439,378 | 5,959,595 | SH | SOLE | 5,959,595 | 0 | 0 | |||
| UNITED THERAPEUTICS CORP | Common | 91307C102 | 1,559,537,400 | 2,630,000 | SH | SOLE | 2,630,000 | 0 | 0 | |||
| UNITED THERAPEUTICS CORP | Common | 91307C102 | 5,688,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | Common | 91307C102 | 4,608,000 | 180,000 | SH | Call | SOLE | 180,000 | 0 | 0 | ||
| VERA THERAPEUTICS INC | Common | 92337R101 | 236,909,964 | 5,888,888 | SH | SOLE | 5,888,888 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | Common | 92790C104 | 29,340,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| WHITEHAWK THERAPEUTICS INC | Common | 00032Q104 | 9,830,437 | 2,849,402 | SH | SOLE | 2,849,402 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 335,977,733 | 5,777,777 | SH | SOLE | 5,777,777 | 0 | 0 | |||